Uddhav Thackeray's aggression

Uddhav Thackeray's aggression

From all accounts, Shiv Sena chief Uddhav Thackeray appears an unlikely candidate for a skirmish...
Verdict on Robert Vadra case today

Verdict on Robert Vadra case today

A PIL is seeking a court-monitored CBI probe into various land deals allegedly entered into by Robert Vadra's firms.

GlaxoSmithKline to launch late-stage clinical trials on 10 new drugs: report

Feb 03 2014, 11:56 IST
Comments 0
GlaxoSmithKline, Britain's biggest drugmaker, is set to unveil plans to launch late-stage clinical trials on 10 new drugs over the next 2 years. GlaxoSmithKline, Britain's biggest drugmaker, is set to unveil plans to launch late-stage clinical trials on 10 new drugs over the next 2 years.
SummaryGSK's new drugs, which have not been detailed to investors, will include cancer and respiratory disease medicines.

GlaxoSmithKline is set to unveil plans to launch late-stage clinical trials on 10 new drugs over the next two years, the Telegraph reported, without citing sources.

The new drugs, which have not been detailed to investors, will include cancer and respiratory disease medicines, the newspaper said on its website.

Britain's biggest drugmaker is also expected to report that fourth-quarter sales in China, where it is embroiled in a major bribery probe, took a smaller hit than when the scandal first blew up during the summer quarter, the report said.

The investigation began in July 2013, after Chinese police accused GSK of funneling up to 3 billion yuan ($495.05 million) to travel agencies to facilitate bribes to boost its drug sales.

Ads by Google

More from Latest News - Industry

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...